1. Sfeir MM. Burkholderia cepacia complex infections: More complex than the bacterium name suggest. J Infect. 2018 Sep;77(3):166–70.
2. Lipsky BA, Senneville É, Abbas ZG, Aragón‐Sánchez J, Diggle M, Embil JM, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev [Internet]. 2020 Mar 16;36(S1). Disponível em: https://onlinelibrary.wiley.com/doi/abs/10.1002/dmrr.3280
3. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard—Eleventh Edition: M07-A11. Wayne, PA, USA; 2018.
4. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers [1]. Diabet Med [Internet]. 2002 Dec;19(12):1032–4. Disponível em: http://doi.wiley.com/10.1046/j.1464-5491.2002.00696_1.x
5. Saeed K, Esposito S, Akram A, Ascione T, Bal AM, Bassetti M, et al. Hot topics in diabetic foot infection. Int J Antimicrob Agents [Internet]. 2020 Jun;55(6):105942. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S0924857920300923
6. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am J Respir Crit Care Med [Internet]. 2003 Oct 15;168(8):918–51. Disponível em: http://www.atsjournals.org/doi/abs/10.1164/rccm.200304-505SO
7. Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Antimicrob Agents Chemother [Internet]. 2007 Mar;51(3):1085–8. Disponível em: https://journals.asm.org/doi/10.1128/AAC.00954-06
8. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman DG, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement [Internet]. PLoS Medicine Jul 21, 2009 p. e1000097. Disponível em: https://dx.plos.org/10.1371/journal.pmed.1000097
9. International Prospective Register of Systematic Reviews (PROSPERO) [Internet]. [cited 2022 Sep 2]. Disponível em: https://www.crd.york.ac.uk/prospero/#guidancenotes
10. Ku NS, Han SH, Kim CO, Baek JH, Jeong SJ, Jin SJ, et al. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia. Scand J Infect Dis [Internet]. 2011 Oct 5;43(10):792–7. Disponível em: http://www.tandfonline.com/doi/full/10.3109/00365548.2011.589076
11. Sen P, Demirdal T. Evaluation of mortality risk factors in diabetic foot infections. Int Wound J [Internet]. 2020 Aug 20;17(4):880–9. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/iwj.13343
12. Saran S, Singh VS, Panda S, Gurjar M, Pani KC, Borde K, et al. Disseminated pyomyositis due to Burkholderia cepacia: A case report. Indian J Crit Care Med [Internet]. 2018 Nov;22(11):811–3. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/30598571
13. Fadini GP, Tiengo A, Avogaro A. First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen [3]Y. J Clin Microbiol [Internet]. 2005 Jan;43(1):529. Disponível em: https://journals.asm.org/doi/10.1128/JCM.43.1.529.2005
14. Pathengay A, Raju B, Sharma S, Das T, Endophthalmitis Research Group. Recurrent endophthalmitis caused by Burkholderia cepacia. Eye (Lond) [Internet]. 2005 Mar 30;19(3):358–9. Disponível em: http://www.nature.com/articles/6701501
15. Muda R, Vayavari V, Subbiah D, Ishak H, Adnan A, Mohamed SO. Endogenous endophthalmitis: a 9-year retrospective study at a tertiary referral hospital in Malaysia. J Ophthalmic Inflamm Infect. 2018;8(1).
16. Ibrahim M, Yap JY. Burkholderia cepacia: A rare cause of bacterial keratitis. BMJ Case Rep [Internet]. 2018 Apr 25;2018:bcr-2018-224552. Disponível em: https://casereports.bmj.com/lookup/doi/10.1136/bcr-2018-224552
17. Pope CE, Short P, Carter PE. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand. J Cyst Fibros [Internet]. 2010 Dec;9(6):442–6. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S1569199310001104
18. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health? Emerg Infect Dis [Internet]. 1998 Jun;4(2):221–7. Disponível em: http://www.cdc.gov/ncidod/eid/vol4no2/holmes.htm
19. Woods CW, Brasslar AM, LiPuma JJ, Alexander BD, Clements DA, Weber DJ, et al. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin Infect Dis. 2004;38(9):1243–50.
20. Lauman P, Dennis JJ. Advances in phage therapy: Targeting the Burkholderia cepacia complex. Viruses [Internet]. 2021 Jul 9;13(7):1331. Disponível em: https://www.mdpi.com/1999-4915/13/7/1331